Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biomarkers of Depression and Treatment Response
Sponsor: University of California, San Francisco
Summary
This study is a stratified, parallel-group, single-center study utilizing multimodal imaging techniques to identify biomarkers for Major Depressive Disorder (MDD). The study goal is to identify biomarkers for MDD and treatment response that can be implemented in clinical diagnosis and care as valid and reliable measures, through monitoring neurophysiological and electrophysiological changes across the course of transcranial magnetic stimulation (TMS) treatment.
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2020-12-01
Completion Date
2027-09
Last Updated
2026-01-30
Healthy Volunteers
No
Conditions
Interventions
rTMS therapy
rTMS treatment parameters will be determined by TMS care providers. Typical TMS settings for MDD involve rTMS applied at 10 Hz with an intensity of 120 % of resting motor threshold. Forty trains of 4 s duration with 11s of trains is typically applied (3000 pulses per day), resulting in approximately 90,000 pulses in a given treatment course.
Locations (1)
University of California, San Francisco
San Francisco, California, United States